Skip to main content

Holiday schedule

Quest Diagnostics Patient Service Centers will have modified hours during the holiday season.

  • Closing early at 12:00pm on December 31, 2025
  • Closed on January 1, 2026


Have a healthy, happy holiday!

Hide
Quest Diagnostics

Diagnostic Utility of NGS Panel Testing Including Non-coding and Mitochondrial DNA Variants in Patients With Monogenic Diabetes

Sociedade Portuguesa de Genetica Humana
26th Annual Meeting

SPGH  2022

Coimbra, Portugal, November 17 - 19, 2022

Poster presentation: Diagnostic utility of NGS panel testing including non-coding and mitochondrial DNA variants in patients with monogenic diabetes

Authors: Scocchia A, Sánchez-Alcudia R, Känsäkoski J, Gall K, Hathaway J, Taylor A, Huusko J, Bernal M, von Nandelstadh P, Tommiska J, Saarinen I, Rantanen M, Schleit J, Gentile M, Salmenperä P, Paananen J, Myllykangas S, Koskenvuo J.

Specialties: Cardiology, Endocrinology, Genetics

Disclaimer:  One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.